Chemical Compound Review:
PENBUTOLOL(-) 1-(2-cyclopentylphenoxy)-3- (tert...
Synonyms:
SureCN49358, BSPBio_000966, SPBio_002903, BPBio1_001064, AC1L1ITB, ...
- Effects of penbutolol and metoprolol on blood pressure, plasma catecholamines and renin activity in hypertensive patients. Hansson, B.G., Dymling, J.F., Manhem, P., Hökfelt, B. Eur. Heart J. (1983)
- Haemodynamic dose-response effects of i.v. penbutolol in angina pectoris. Silke, B., Verma, S.P., Hussain, M., Nelson, G.I., Okoli, R.C., Taylor, S.H. British journal of clinical pharmacology. (1983)
- Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man. Giudicelli, J.F., Richer, C., Chauvin, M., Idrissi, N., Berdeaux, A. British journal of clinical pharmacology. (1977)
- Usefulness of penbutolol for systemic hypertension. Penbutolol Research Group. Schoenberger, J.A. Am. J. Cardiol. (1989)
- Absence of genotoxic activity of penbutolol in bacterial and mammalian cell screening systems. Müller, W., Cojocel, C., Kramer, W., Mayer, D. Mutat. Res. (1990)
- The effect of single doses of penbutolol and propranolol L.A. on psychomotor performance. Broadhurst, A.D., Monaghan, A.T. British journal of clinical pharmacology. (1984)
- Does a single priming injection of clenbuterol alter behavioral response to beta-adrenoceptor agonists and antagonists in mice through a time-dependent process? Martin, P., Soubrie, P., Simon, P. Eur. J. Pharmacol. (1985)
- A comparative study of atenolol and penbutolol in hypertensive patients. Lameijer, L.D., Houtzagers, J.J., Voermans, L.A. Eur. Heart J. (1983)
- Single and divided doses of penbutolol. Müller, F.O., Hundt, H.K., Bromley, P.A., Torres, J., Vanderbeke, O. Clin. Pharmacol. Ther. (1979)
- Beta-2 adrenoceptor blocking activity of penbutolol and propranolol at very low doses. Kulkarni, R.D., DaSilva, L.M., Chabria, N.L., Chadha, D.R. Clin. Pharmacol. Ther. (1977)
- Liquid-chromatographic determination of penbutolol and its principal metabolites in plasma and urine. Miner, D.J., Binkley, D.A., Bechtol, L.D. Clin. Chem. (1984)
- A comparison of a combination of penbutolol and frusemide with the two compounds individually in the treatment of hypertension. Chadha, D.R., Houtzagers, J.J. British journal of clinical pharmacology. (1983)
- Penbutolol and propranolol: a comparison of their effects on antipyrine clearance in man. Bax, N.D., Jones, R.W., Lennard, M.S., Tucker, G.T., Woods, H.F. British journal of clinical pharmacology. (1985)
- Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol. Lameijer, L.D., Voermans, L.A., Houtzagers, J.J., Chadha, D.R. Eur. J. Clin. Pharmacol. (1981)
- Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension. Verho, M., Rangoonwala, B., Pahnke, K., Freude, J., Häringer, E. Drugs under experimental and clinical research. (1985)
- Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia. Hansson, B.G., Hökfelt, n.u.l.l. Eur. J. Clin. Pharmacol. (1976)
- The membrane stabilizing activity of beta-adrenoceptor ligands. Quantitative evaluation of the interaction of phenoxypropanolamines with the [3H]batrachotoxinin A 20-alpha-benzoate binding site on voltage-sensitive sodium channels in rat brain. Ijzerman, A.P., Nagesser, A., Garritsen, A. Biochem. Pharmacol. (1987)
- Penbutolol in the treatment of mild to moderate essential hypertension in black South Africans. Venter, C.P., Joubert, P.H., Venter, H.L., Muntingh, G.L., du Plooy, W.J. Journal of clinical pharmacology. (1990)
- Decrease in penbutolol protein binding as a consequence of treatment with some alkylating agents. Aguirre, C., Rodríguez-Sasiain, J.M., Calvo, R. Cancer Chemother. Pharmacol. (1994)
- The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat. Lewis, M.J. Br. J. Pharmacol. (1977)
- DNA strand breaks and mutations caused by penbutolol, a beta blocker. Hussain, S.S., Al-Dakan, A.A., Aboul-Enein, H.Y., Hannan, M.A. Mutat. Res. (1988)
- Penbutolol: beta-adrenoceptor interaction and the time course of plasma concentrations explain its prolonged duration of action in man. Wellstein, A., Palm, D. Eur. J. Clin. Pharmacol. (1985)
- In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. Hjorth, S., Sharp, T. J. Pharmacol. Exp. Ther. (1993)
- Studies on the stereoisomers of beta-adrenoceptor antagonists in conscious A-V blocked dogs. Boucher, M., Duchêne-Marullaz, P., Moundanga, J.L. Br. J. Pharmacol. (1986)
- Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Gundlah, C., Hjorth, S., Auerbach, S.B. Neuropharmacology (1997)
- Plasma level studies of penbutolol after oral dose in man. Vallner, J.J., Jun, H.W., Needham, T.E., Stewart, J.T., Brown, W., Frazer, H., Honigberg, I.L. Journal of clinical pharmacology. (1977)
- Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs. Park, B.K. British journal of clinical pharmacology. (1984)
- Increase in the isolation-induced social behavioural deficit by agonists at 5-HT1A receptors. Francès, H., Khidichian, F., Monier, C. Neuropharmacology (1990)
- Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Heel, R.C., Brogden, R.N., Speight, T.M., Avery, G.S. Drugs (1981)
- Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography. Bernard, N., Cuisinaud, G., Sassard, J. J. Chromatogr. (1982)